{"disease":{"id":"neutropenia","name":"neutropenia"},"drugs":{"marketed":[{"drug_id":"nivestym","indication_name":"Chemotherapy-induced neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neupogen","generic_name":"Filgrastim-Aafi","company_name":"Amgen","drug_phase":"marketed","molecular_target":"G-CSF receptor (granulocyte colony-stimulating factor receptor)","drug_class":"Colony-stimulating factor (CSF); leukocyte growth factor","quality_score":10,"revenue":"1434.0","mechanism":"Filgrastim-aafi binds G-CSF receptors on hematopoietic cells, stimulating neutrophil proliferation, differentiation, and functional activation."},{"drug_id":"nivestym","indication_name":"Chronic idiopathic neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neupogen","generic_name":"Filgrastim-Aafi","company_name":"Amgen","drug_phase":"marketed","molecular_target":"G-CSF receptor (granulocyte colony-stimulating factor receptor)","drug_class":"Colony-stimulating factor (CSF); leukocyte growth factor","quality_score":10,"revenue":"1434.0","mechanism":"Filgrastim-aafi binds G-CSF receptors on hematopoietic cells, stimulating neutrophil proliferation, differentiation, and functional activation."},{"drug_id":"nivestym","indication_name":"Congenital neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neupogen","generic_name":"Filgrastim-Aafi","company_name":"Amgen","drug_phase":"marketed","molecular_target":"G-CSF receptor (granulocyte colony-stimulating factor receptor)","drug_class":"Colony-stimulating factor (CSF); leukocyte growth factor","quality_score":10,"revenue":"1434.0","mechanism":"Filgrastim-aafi binds G-CSF receptors on hematopoietic cells, stimulating neutrophil proliferation, differentiation, and functional activation."},{"drug_id":"nivestym","indication_name":"Cyclical neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neupogen","generic_name":"Filgrastim-Aafi","company_name":"Amgen","drug_phase":"marketed","molecular_target":"G-CSF receptor (granulocyte colony-stimulating factor receptor)","drug_class":"Colony-stimulating factor (CSF); leukocyte growth factor","quality_score":10,"revenue":"1434.0","mechanism":"Filgrastim-aafi binds G-CSF receptors on hematopoietic cells, stimulating neutrophil proliferation, differentiation, and functional activation."},{"drug_id":"lipegfilgrastim","indication_name":"Chemotherapy-induced neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lonquex","generic_name":"LIPEGFILGRASTIM","company_name":"Sicor Biotech UAB","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"","quality_score":28,"revenue":"1200","mechanism":""},{"drug_id":"nyvepria","indication_name":"Chemotherapy-induced neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neulasta","generic_name":"Pegfilgrastim-Apgf","company_name":"Amgen","drug_phase":"marketed","molecular_target":"G-CSF receptor on hematopoietic cells","drug_class":"Colony-stimulating factor","quality_score":10,"revenue":"1200","mechanism":"Colony-stimulating factor binding hematopoietic cell surface receptors to stimulate proliferation and differentiation."},{"drug_id":"neupogen","indication_name":"Cyclical neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Neupogen","company_name":"University of Chicago","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"sargramostim","indication_name":"Chemotherapy-induced neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Leukine","generic_name":"SARGRAMOSTIM","company_name":"Berlex Labs","drug_phase":"marketed","molecular_target":"Granulocyte macrophage colony-stimulating factor receptor","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":10,"revenue":null,"mechanism":"Leukine works by binding to the granulocyte macrophage colony-stimulating factor receptor, stimulating the production of white blood cells."},{"drug_id":"eflapegrastim-xnst","indication_name":"Febrile neutropenia caused by myelosuppressive anti-cancer drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"ROLVEDON","generic_name":"EFLAPEGRASTIM-XNST","company_name":"SPECTRUM PHARMS","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"leukine","indication_name":"Chemotherapy-induced neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Leukine","company_name":"University of Kentucky","drug_phase":"discontinued","molecular_target":"Granulocyte macrophage colony-stimulating factor receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"pegfilgrastim-jmdb","indication_name":"Chemotherapy-induced neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"FULPHILA","generic_name":"PEGFILGRASTIM-JMDB","company_name":"MYLAN GMBH","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"eflapegrastim","indication_name":"Febrile neutropenia caused by myelosuppressive anti-cancer drugs","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rolvedon","generic_name":"EFLAPEGRASTIM","company_name":"Spectrum Pharms","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":48,"revenue":null,"mechanism":"Rolvedon works by binding to the granulocyte colony-stimulating factor receptor, stimulating the production of white blood cells."},{"drug_id":"nipent","indication_name":"Hairy cell leukemia patients with neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nipent","generic_name":"Pentostatin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Adenosine deaminase (ADA)","drug_class":"Nucleoside Metabolic Inhibitor [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"pegfilgrastim","indication_name":"Chemotherapy-induced neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Neulasta","generic_name":"PEGFILGRASTIM","company_name":"Amgen","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":70,"revenue":null,"mechanism":"Neulasta stimulates the production of white blood cells by binding to their receptors."},{"drug_id":"filgrastim-txid","indication_name":"Febrile Neutropenia in Nonmyeloid Malignancies","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"NYPOZI","generic_name":"FILGRASTIM-TXID","company_name":"TANVEX BIOPHARMA USA INC","drug_phase":"marketed","molecular_target":"Specific cell surface receptors on hematopoietic cells","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":50,"revenue":null,"mechanism":"G-CSF binds to specific receptors on hematopoietic cells, stimulating neutrophil production and function."},{"drug_id":"neulasta","indication_name":"Chemotherapy-induced neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Neulasta","company_name":"Columbia University","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"filgrastim-txid","indication_name":"Neutropenia in BMT","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"NYPOZI","generic_name":"FILGRASTIM-TXID","company_name":"TANVEX BIOPHARMA USA INC","drug_phase":"marketed","molecular_target":"Specific cell surface receptors on hematopoietic cells","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":50,"revenue":null,"mechanism":"G-CSF binds to specific receptors on hematopoietic cells, stimulating neutrophil production and function."},{"drug_id":"filgrastim-txid","indication_name":"Severe Chronic Neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"NYPOZI","generic_name":"FILGRASTIM-TXID","company_name":"TANVEX BIOPHARMA USA INC","drug_phase":"marketed","molecular_target":"Specific cell surface receptors on hematopoietic cells","drug_class":"Leukocyte Growth Factor [EPC]","quality_score":50,"revenue":null,"mechanism":"G-CSF binds to specific receptors on hematopoietic cells, stimulating neutrophil production and function."},{"drug_id":"neupogen","indication_name":"Chemotherapy-induced neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Neupogen","company_name":"University of Chicago","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"neupogen","indication_name":"Chronic idiopathic neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Neupogen","company_name":"University of Chicago","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"neupogen","indication_name":"Congenital neutropenia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Neupogen","company_name":"University of Chicago","drug_phase":"marketed","molecular_target":"Granulocyte colony-stimulating factor receptor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":21,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT02728596","title":"S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)","phase":"NA","overall_status":"COMPLETED","enrollment_count":3665,"lead_sponsor_name":"SWOG Cancer Research Network","has_results":true},{"nct_id":"NCT03618810","title":"Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT03846414","title":"Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06908616","title":"Prevalence of Ethnic Neutropenia and Duffy Null Phenotype in Neonates","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Kaplan Medical Center","has_results":false},{"nct_id":"NCT02178475","title":"Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy","phase":"","overall_status":"COMPLETED","enrollment_count":943,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT00911170","title":"PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":847,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT03798665","title":"A Real World Study Evaluating the Clinical Application of PEG-rhG-CSF During Chemotherapy in Patients With Solid Tumors","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Affiliated Hospital of North Sichuan Medical College","has_results":false},{"nct_id":"NCT04460079","title":"Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN","phase":"","overall_status":"COMPLETED","enrollment_count":654,"lead_sponsor_name":"Cinnagen","has_results":false},{"nct_id":"NCT03740464","title":"Long-acting G-CSF for Febrile Neutropenia","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":556,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT05206006","title":"Impact of Computerized Decision Support for ANTIBIOtic Prescription in Cancer Patients With Febrile NEutropenia in the Emergency Department on Treatment Failure.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":540,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT01307579","title":"Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":517,"lead_sponsor_name":"Children's Oncology Group","has_results":true},{"nct_id":"NCT05585463","title":"Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2021)","phase":"","overall_status":"COMPLETED","enrollment_count":460,"lead_sponsor_name":"Fundació Sant Joan de Déu","has_results":false},{"nct_id":"NCT02643420","title":"SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":406,"lead_sponsor_name":"Spectrum Pharmaceuticals, Inc","has_results":true},{"nct_id":"NCT05815628","title":"Next-Generation-Sequencing Approach to Neutropenic Sepsis","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Boris Böll","has_results":false},{"nct_id":"NCT03252431","title":"Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":393,"lead_sponsor_name":"EVIVE Biotechnology","has_results":true},{"nct_id":"NCT01126190","title":"Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":381,"lead_sponsor_name":"Teva Branded Pharmaceutical Products R&D, Inc.","has_results":true},{"nct_id":"NCT04669418","title":"Host RNA Signature in Children With Cancer and Infection","phase":"","overall_status":"COMPLETED","enrollment_count":370,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT06616571","title":"Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":336,"lead_sponsor_name":"Qilu Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT00837265","title":"Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":334,"lead_sponsor_name":"Teva Branded Pharmaceutical Products R&D, Inc.","has_results":true},{"nct_id":"NCT07096479","title":"Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor","phase":"","overall_status":"RECRUITING","enrollment_count":318,"lead_sponsor_name":"Anhui Provincial Hospital","has_results":false},{"nct_id":"NCT03968328","title":"Time From Onset of Fever to Administration of Antibiotics in Neutropenic Fever Patients","phase":"","overall_status":"COMPLETED","enrollment_count":315,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05245487","title":"Danish Elder Lymphoma Patient Hematopoietic Investigation","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT05149547","title":"mNGS Versus Blood Culture in FN","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06809101","title":"Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.","phase":"","overall_status":"RECRUITING","enrollment_count":265,"lead_sponsor_name":"Pomeranian Medical University Szczecin","has_results":false},{"nct_id":"NCT06278896","title":"Early Neutropenic Fever De-escalation of Antibiotics Study","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":260,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT06711523","title":"Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Kexing Biopharm Co., Ltd.","has_results":false},{"nct_id":"NCT04174599","title":"Study to Compare the Efficacy and Safety of F-627 and GRAN®","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":242,"lead_sponsor_name":"EVIVE Biotechnology","has_results":true},{"nct_id":"NCT04217811","title":"Late Neutropenia in VLBW Preterm Babies","phase":"","overall_status":"COMPLETED","enrollment_count":237,"lead_sponsor_name":"Hillel Yaffe Medical Center","has_results":false},{"nct_id":"NCT02953340","title":"SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":237,"lead_sponsor_name":"Spectrum Pharmaceuticals, Inc","has_results":true},{"nct_id":"NCT06787326","title":"Effect of the BioFire FilmArray (BCID2) for the Rapid Detection of Bloodstream Infection in Haematologic Patients With Febrile Neutropenia","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":228,"lead_sponsor_name":"Hospital Universitari de Bellvitge","has_results":false},{"nct_id":"NCT06422533","title":"Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":226,"lead_sponsor_name":"Instituto Nacional de Cancerologia de Mexico","has_results":false},{"nct_id":"NCT07192770","title":"G-CSF-Induced Bone Pain and Supportive Care Approaches","phase":"","overall_status":"COMPLETED","enrollment_count":225,"lead_sponsor_name":"Ankara Etlik City Hospital","has_results":false},{"nct_id":"NCT03294577","title":"Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":221,"lead_sponsor_name":"BeyondSpring Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT02465801","title":"Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":216,"lead_sponsor_name":"Tianjin SinoBiotech Ltd.","has_results":false},{"nct_id":"NCT05576220","title":"Remote Temperature Monitoring of Adult Subjects Undergoing Outpatient Stem Cell Transplant or CAR-T Cell Therapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":210,"lead_sponsor_name":"IDION Inc.","has_results":false},{"nct_id":"NCT07434063","title":"Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Hebei Medical University Fourth Hospital","has_results":false},{"nct_id":"NCT04662892","title":"An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Coherus Oncology, Inc.","has_results":false},{"nct_id":"NCT06649448","title":"A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Shandong Cancer Hospital and Institute","has_results":false},{"nct_id":"NCT04101760","title":"Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT02135887","title":"A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer.","phase":"","overall_status":"UNKNOWN","enrollment_count":184,"lead_sponsor_name":"Microbio Co Ltd","has_results":false},{"nct_id":"NCT05672420","title":"Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":181,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT00059423","title":"Natural History Study for BEN","phase":"","overall_status":"COMPLETED","enrollment_count":178,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT07372131","title":"Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":172,"lead_sponsor_name":"Humanitas University","has_results":false},{"nct_id":"NCT04460508","title":"Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":170,"lead_sponsor_name":"The First Hospital of Jilin University","has_results":false},{"nct_id":"NCT04710212","title":"Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies","phase":"","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT07113314","title":"Prophylaxis of Febrile Neutropenia With Lactoferrin in Oncohematologic Children Undergoing Induction Chemotherapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT05311254","title":"A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":156,"lead_sponsor_name":"Fundación para la Investigación Biosanitaria del Principado de Asturias","has_results":false},{"nct_id":"NCT03498248","title":"Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":155,"lead_sponsor_name":"DERSHENG SUN","has_results":false},{"nct_id":"NCT04233996","title":"Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Hospital Universitari de Bellvitge","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}